Laboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, 54 124 Thessaloniki, Greece.
School of Pharmacy, Department of Pharmaceutical Technology, Istanbul Medipol University, Beykoz, 34810 Istanbul, Turkey.
Int J Mol Sci. 2016 Feb 25;17(3):282. doi: 10.3390/ijms17030282.
In this work, a comparison between two different preparation methods for the improvement of dissolution rate of an antifungal agent is presented. Poly(ε-caprolactone) (PCL) electrospun fibers and β-cyclodextrin (β-CD) complexes, which were produced via an electrospinning process and an inclusion complexation method, respectively, were addressed for the treatment of fungal infections. Voriconazole (VRCZ) drug was selected as a model drug. PCL nanofibers were characterized on the basis of morphology while phase solubility studies for β-CDs complexes were performed. Various concentrations (5, 10, 15 and 20 wt %) of VRCZ were loaded to PCL fibers and β-CD inclusions to study the in vitro release profile as well as in vitro antifungal activity. The results clearly indicated that all formulations showed an improved VRCZ solubility and can inhibit fungi proliferation.
本文介绍了两种不同的方法来改善一种抗真菌药物的溶出速率,通过静电纺丝工艺和包合作用分别制备了聚己内酯(PCL)电纺纤维和β-环糊精(β-CD)复合物,用于治疗真菌感染。伏立康唑(VRCZ)药物被选为模型药物。基于形态学对 PCL 纳米纤维进行了表征,同时对β-CD 配合物进行了相溶解度研究。将不同浓度(5、10、15 和 20wt%)的 VRCZ 负载到 PCL 纤维和β-CD 包合物上,以研究体外释放曲线和体外抗真菌活性。结果清楚地表明,所有制剂都显示出改善的 VRCZ 溶解度,并能抑制真菌的增殖。